Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 13/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 13/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.36 |
| ▸ | HPGD | P15428 | 9/20 | 0.36 |
| ▸ | MAPT | P10636 | 8/20 | 0.36 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 2/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16723878 | 0.87 | ALOX5 (0.36) | — | |
| SCHEMBL16723923 | 0.86 | ALOX5 (0.37) | — | |
| SCHEMBL16723903 | 0.85 | ALOX5 (0.35) | — | |
| SCHEMBL16723936 | 0.84 | ALOX5 (0.32) | — | |
| SCHEMBL16723595 | 0.84 | ALOX5 (0.32) | — | |
| SCHEMBL19777618 | 0.83 | MEN1 (0.36) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL19777614 | 0.82 | MEN1 (0.40) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL19777622 | 0.81 | MEN1 (0.38) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL19777619 | 0.81 | MEN1 (0.38) | MEN1KMT2AALDH1A1HPGDMAPT | |
| SCHEMBL16723926 | 0.81 | ALOX5 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9368733-B2 | Compound for organic optoelectronic device, organic light-emitting device containing the same, and display device including said organic light-emitting device | SAMSUNG SDI CO., LTD. (KR) | 2016-06-14 | — | — | US | disclosed |
| US-9368733-B2 | Compound for organic optoelectronic device, organic light-emitting device containing the same, and display device including said organic light-emitting device | SAMSUNG SDI CO., LTD. (KR) | 2016-06-14 | — | — | US | disclosed |
| US-20150137111-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME, AND DISPLAY DEVICE INCLUDING SAID ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-05-21 | — | — | US | disclosed |
| US-20150137111-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME, AND DISPLAY DEVICE INCLUDING SAID ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG SDI CO., LTD. (KR) | 2015-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150137111-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT-EMITTING DEVICE CONTAINING THE SAME, AND DISPLAY DEVICE INCLUDING SAID ORGANIC LIGHT-EMITTING DEVICE | OR51E2, AOX1, OCIAD1 | MEN1 2370/4885KMT2A 2690/4885ALDH1A1 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.